NCT07262528

Brief Summary

Cardiovascular diseases are one of the main causes of disability. Among post-stroke individuals, 80% experience upper limb dysfunction, while only 5% to 20% of individuals regain full limb and hand function. The purpose of this study is to evaluate the effects of hand rehabilitation of post-stroke individuals using HEG Neurofeedback The study will include 30 participants in the early sub-acute phase post-stroke, who will be assigned to either the study group or the control group. Participants in the experimental group will follow a rehabilitation program extended with HEG Neurofeedback training, while participants in the control group will follow the standard rehabilitation program. The HEG Neurofeedback therapy equipment will be supplemented with new hand therapy software. During the exercises, patients will focus on a discussed and presented task, and once the expected level of concentration is reached, the software will trigger a virtual hand performing a finger flexion movement. Motor control of the hand will be assessed using the Fugl-Meyer Scale and Brunnström recovery stages.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 6, 2026

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

September 28, 2025

Last Update Submit

April 20, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Hand motor control - Fugl-Meyer Assessment (Upper Limb, Wrist, and Hand Section)

    Assessment will be performed using the Fugl-Meyer Assessment for the upper limb, including wrist and hand function, to evaluate motor recovery after stroke. The wrist section has a minimum score of 0 and a maximum score of 10, while the hand section has a minimum score of 0 and a maximum score of 14. In both sections, higher scores indicate better motor function.

    Baseline (Day 1)

  • Hand motor control - Fugl-Meyer Assessment (Upper Limb, Wrist, and Hand Section)

    Assessment will be performed using the Fugl-Meyer Assessment for the upper limb, including wrist and hand function, to evaluate motor recovery after stroke. The wrist section has a minimum score of 0 and a maximum score of 10, while the hand section has a minimum score of 0 and a maximum score of 14. In both sections, higher scores indicate better motor function.

    Immediately after therapy completion (Day 15)

  • Hand motor control - Brunnström Recovery Stages (Hand Section)

    Assessment will be performed using the hand section of the Brunnström Recovery Stages to classify the stage of motor recovery in the affected hand. The scale has a minimum value of 1 and a maximum value of 6. Higher values indicate better motor function and greater voluntary control of hand movements.

    Baseline (Day 1)

  • Hand motor control - Brunnström Recovery Stages (Hand Section)

    Assessment will be repeated using the Brunnström Recovery Stages to determine any progression in hand motor recovery. The scale has a minimum value of 1 and a maximum value of 6. Higher values indicate better motor function and greater voluntary control of hand movements.

    Immediately after therapy completion (Day 15)

Study Arms (2)

Standard Rehabilitation supplemented with Biofeedback HEG

EXPERIMENTAL
Other: Standard Rehabilitation supplemented with Biofeedback HEG

Control: Standard Rehabilitation

OTHER
Other: Standard Rehabilitation

Interventions

The experimental group will be provided with rehabilitation at the Rehabilitation Clinic and additional exercises with Biofeedback HEG. HEG therapy will be conducted for 15 days, every day from Monday to Friday. The duration of one session is 30 minutes. The HEG Neurofeedback therapy equipment will be supplemented with new hand therapy software. During the exercises, patients will focus on a discussed and presented task, and once the expected level of concentration is reached, the software will trigger a virtual hand performing a finger flexion movement.

Standard Rehabilitation supplemented with Biofeedback HEG

Participants from the control group will be provided with rehabilitation at the Rehabilitation Clinic and an additional 30 minutes of individual physiotherapy focused on restoring hand function.

Control: Standard Rehabilitation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals with hemiparesis after a first ischemic stroke,
  • subacute stroke period (no longer than 3 months),
  • upper limb paresis rated 2-4 by Brunnstrom recovery stages,
  • participants aged 18 to 70 years,
  • consent to participate in the study.

You may not qualify if:

  • unstable general condition,
  • visual field disorders,
  • inability to sit independently,
  • cognitive impairment (Mini-Mental State Examination, MMSE \> 24).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rzeszów

Rzeszów, 35-959, Poland

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Agnieszka Guzik

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 28, 2025

First Posted

December 3, 2025

Study Start

December 1, 2025

Primary Completion

January 15, 2026

Study Completion

May 6, 2026

Last Updated

April 21, 2026

Record last verified: 2026-04

Locations